نتایج جستجو برای: guérin bcg

تعداد نتایج: 9027  

Journal: :Blood 2005
Troy J Kemp Aaron T Ludwig James K Earel Jill M Moore Rebecca L Vanoosten Bonita Moses Kevin Leidal William M Nauseef Thomas S Griffith

Mycobacterium bovis bacillus Calmette-Guérin (BCG) has been used to treat bladder cancer for almost 30 years; however, the effector mechanism of the BCG-induced antitumor response remains enigmatic. Most BCG research has focused on the mononuclear-cell infiltrate, but growing evidence supports a role for neutrophils in the antitumor response. Previously, we demonstrated increased urinary tumor ...

2009
Kyung Seok Han Sung Joon Hong

Purpose: Bacillus Calmette-Guérin (BCG) intravesical therapy is the standard treatment in high-risk patients with non-muscle-invasive bladder cancer, but a significant number of patients experience recurrence after BCG therapy. Although several treatment options are available for recurrence after BCG therapy, the optimal treatment strategy is still controversial. We reviewed current and promisi...

Journal: :Egyptian Journal of Bronchology 2021

Abstract Background The paper aimed to analyze and evaluate the present literature data on clinical effectiveness of using bacillus Calmette–Guérin (BCG) vaccine in protecting against novel coronavirus disease 2019 (COVID-19). Main body Several have shown a relationship between vaccinated population with severity mortality rate from However, linkage BCG COVID-19 infection morbidity is still amb...

Journal: :Infection and immunity 2001
B G Marshall A Wangoo P O'Gaora H T Cook R J Shaw D B Young

With a view to exploring the role of transforming growth factor beta (TGF-beta) during mycobacterial infection, recombinant clones of bacillus Calmette-Guérin (BCG) were engineered to express the natural antagonist of TGF-beta, latency-activated peptide (LAP). Induction of TGF-beta activity was reduced when macrophages were infected with BCG expressing the LAP construct (LAP-BCG). There was a s...

Journal: :Communicable diseases intelligence quarterly report 2006

The Bacille Calmette-Guérin (BCG) vaccine since its first use in 1921 has been the subject of much controversy as to its effectiveness and applicability. BCG vaccination is still considered an important strategy in the National Tuberculosis Programs of countries with a high burden of tuberculosis (TB) because of its benefit to infants but its effect on the control of TB has been limited. By con...

2014
Kathrin Buffen Marije Oosting Jessica Quintin Aylwin Ng Johanneke Kleinnijenhuis Vinod Kumar Esther van de Vosse Cisca Wijmenga Reinout van Crevel Egbert Oosterwijk Anne J. Grotenhuis Sita H. Vermeulen Lambertus A. Kiemeney Frank L. van de Veerdonk Georgios Chamilos Ramnik J. Xavier Jos W. M. van der Meer Mihai G. Netea Leo A. B. Joosten

The anti-tuberculosis-vaccine Bacillus Calmette-Guérin (BCG) is the most widely used vaccine in the world. In addition to its effects against tuberculosis, BCG vaccination also induces non-specific beneficial effects against certain forms of malignancy and against infections with unrelated pathogens. It has been recently proposed that the non-specific effects of BCG are mediated through epigene...

2015
Kristoffer Jarlov Jensen Nanna Larsen Sofie Biering-Sørensen Andreas Andersen Helle Brander Eriksen Ivan Monteiro David Hougaard Peter Aaby Mihai G. Netea Katie L. Flanagan Christine Stabell Benn

BACKGROUND Bacillus Calmette-Guérin (BCG) seems to have beneficial nonspecific effects; early BCG vaccination of low-birth-weight (LBW) newborns reduces neonatal mortality by >40% due to prevention of primarily septicemia and pneumonia. METHODS Within a randomized trial in LBW infants in Guinea-Bissau of early BCG vs the usual postponed BCG, a subgroup was bled 4 weeks after randomization. Le...

Journal: :Molecular cancer therapeutics 2015
Zhiqun Shang Yanjun Li Minghao Zhang Jing Tian Ruifa Han Chih-Rong Shyr Edward Messing Shuyuan Yeh Yuanjie Niu Chawnshang Chang

Recent studies suggest that the androgen receptor (AR) might play important roles in influencing bladder cancer progression, yet its clinical application remains unclear. Here, we developed a new combined therapy with Bacillus Calmette-Guérin (BCG) and the AR degradation enhancer ASC-J9 or antiandrogen hydroxyflutamide (HF) to better suppress bladder cancer progression. Mechanism dissection rev...

Journal: :Blood 2005
Valérie Abadie Edgar Badell Patrice Douillard Danielle Ensergueix Pieter J M Leenen Myriam Tanguy Laurence Fiette Sem Saeland Brigitte Gicquel Nathalie Winter

The early innate response after Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination is poorly characterized but probably decisive for subsequent protective immunity against tuberculosis. Therefore, we vaccinated mice with fluorescent BCG strains in the ear dorsum, as a surrogate of intradermal vaccination in humans. During the first 3 days, we tracked BCG host cells migrating out of t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید